The next step in the yearslong cannabis rescheduling process could be a brief hearing where an administrative law judge informs witnesses why they aren’t qualified to participate, observers told MJBizDaily.
Ahead of a Nov. 12 deadline, cannabis advocates and business leaders invited to participate in a Dec. 2 hearing about cannabis rescheduling were asked to explain how they would be harmed by moving the plant from Schedule 1 to Schedule 3 of the Controlled Substances Act
To do that, anyone in favor of rescheduling cannabis had to reconcile two seemingly counterintuitive ideas if they wanted to engage in the process, according to interviews and a review of filings obtained by MJBizDaily:
- Retaining cannabis as a Schedule 1 drug is untenable.
- Moving cannabis to Schedule 3 without imposing other controls also “adversely” affects them.
It might seem like a delicate balancing act – if not outright contradictory.
This item originally appeared on MJBizDaily. The rest of the story is available here.
